Open wounds and rifampicin therapy are associated with rifampicin resistance among staphylococcal vascular graft/endograft infections.

Yau Kei Stefan LeungBruno LedergerberNadia EberhardCarlos A MestresZoran RancicAlexander ZimmermannReinhard ZbindenSilvio Daniel Brugger Annelies S ZinkernagelBarbara Hassenull null

Published in: JAC-antimicrobial resistance (2021)

Rifampicin should be started after wound closure due to increased risk of rifampicin resistance observed while having open wounds or second-look surgeries among patients with S-VGEI.

Keyphrases

mycobacterium tuberculosis
pulmonary tuberculosis
minimally invasive
wound healing
methicillin resistant staphylococcus aureus
bone marrow
mesenchymal stem cells
surgical site infection
smoking cessation
abdominal aortic